SynthesisFrontiers in oncology2023

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis.

Muyesar Alifu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.